A Retrospective Study of Comparison of Two Common Radiation Therapy Techniques for Definitive Treatment of Localized Esophageal Squamous Cell Cancer

H. Liu,Q. Wang,T. Li,J. Lang,X. Jia,B. Liu

DOI: https://doi.org/10.1016/j.ijrobp.2015.07.864

2015-01-01

Abstract:Two choices are widely used for radiation delivery in China, 3-dimensional conformal radiation therapy (3D-CRT) and conventional external beam radiation and neutron brachytherapy (EBRT+NBT). No randomized comparisons have been conducted in the setting of esophageal cancer. We analyzed two cancer center a large cohort of localized esophageal squamous cell carcinoma (ESCC) patients treated from 3D-CRT to EBRT+NBT to compare outcomes. Patients with ESCC treated with definitive radiation at two institutions between 2002 and 2012 were retrospectively reviewed. Multivariable Cox regression was used to compare oncologic outcomes of NBT+EBRT and 3D-CRT in the context of other clinically relevant variables. Acute and chronic toxicities associated with the 2 techniques were compared using Fisher exact and log-rank tests, respectively. A total of 884 patients were treated during the study period, there were 583 men and 301 women. 339 and 545 underwent 3DCRT NBT+EBRT. The median age was 66 years (range, 36-93 years). Median follow-up time was 32 months, respectively. The overall median survival was 20.3 months. Three and 5-year OS rates were 37.2% and 26.6%, respectively. 5-y LC rate for the whole group was 47.1%. Radiation modality was associated significantly with differences in OS or LC in either multivariable or univariable analyses. To further confirm the treatment modality as a prognostic factor, we compared the two subgroups of patients who were tested to be early-stage (I+II) or advanced stage (III). In the stage I+II group, the 5-year OS and LC rate in the patients who were treated with 3D-CRT were significantly lower than the patients who were treated with EBRT+NBT (with p = 0.004 and 0.045, respectively, for OS and LC). In the stage III group, the differences in 5-year OS rate and LC rate between the two treatment modalities were less obvious (with p=0.306 and 0.175, respectively, for OS and LC). There were 195 recurrences (35.7%), among which 170 (31.2%) were in-field recurrences and 25 (4.6%) were out-of-field recurrences. In terms of acute toxicity, no perforations were observed during this treatment period. Among which the NBT+EBRT group have significantly higher rate of leukopenia and thrombocytopenia (with p<0.001 for both). For late toxicity, fistula and massive bleeding were observed in both groups of patients, of which the 3D-CRT group show higher rate on both effects. In this cohort of patients with ESCC treated with NBT+EBRT were associated with better oncologic outcomes than those of 3D-CRT. NBT+EBRT were associated with a higher rate of acute irradiation toxicity. 3D-CRT has the higher rate of late toxicity esophageal fistulas.